Psyence Biomed (Newcourt Acquisition) ^{Priced, Nasdaq: PBM}

Newcourt Acquisition is a newly formed blank check company. We intend to concentrate our efforts on identifying digital financial services and financial technology (“fintech”) businesses with exposure to emerging markets, though we may pursue a business combination outside of those industries. If we elect to pursue an investment outside of those industries, our management’s expertise may not be directly applicable to its evaluation or operation, and the information contained in this prospectus regarding that industry might not be relevant to an understanding of the business that we decide to acquire. Our team has global industry knowledge gained from 68 combined years of operating and investing in emerging markets. We believe that our management team, board of directors and strategic advisors’ deep network of contacts and extensive deal execution experience are central to our differentiated acquisition strategy. We will seek to capitalize on the significant investment, technology, financial services, financial technology and banking experience and contacts of our management team, board of directors and advisors to identify, evaluate and acquire a digital financial services or fintech business with exposure to emerging markets.